Provention Bio Inc.

13.90+0.3400+2.51%Vol 333.68K1Y Perf 24.46%
Jul 7th, 2020 11:45 DELAYED
BID13.88 ASK13.92
Open13.41 Previous Close13.56
Pre-Market- After-Market-
 - -%  - -%
Target Price
28.50 
Analyst Rating
Strong Buy 1.17
Potential %
104.89 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Market Cap673.73M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
66.62 
Earnings Date
4th Aug 2020

Today's Price Range

13.3014.28

52W Range

4.7218.50

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-3.90%
1 Month
11.24%
3 Months
61.62%
6 Months
-9.42%
1 Year
24.46%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
PRVB13.900.34002.51
AAPL378.244.39001.17
GOOG1 512.1016.40001.10
MSFT213.172.47001.17
XOM43.71-0.6800-1.53
WFC24.71-0.7800-3.06
JNJ143.320.34000.24
FB247.016.73002.80
GE6.79-0.2100-3.00
JPM92.58-2.4200-2.55
Earnings HistoryEstimateReportedSurprise %
Q01 2020-0.26-0.260.00
Q04 2019-0.23-0.224.35
Q03 2019-0.30-0.2420.00
Q02 2019-0.31-0.32-3.23
Q01 2019-0.19-0.29-52.63
Q04 2018-0.19-0.1521.05
----
----
Earnings Per EndEstimateRevision %Trend
6/2020 QR-0.273.57Positive
9/2020 QR-0.310.00-
12/2020 FY-1.21-7.08Negative
12/2021 FY-1.13-11.88Negative
Next Report Date4th Aug 2020
Estimated EPS Next Report-0.27
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume333.68K
Shares Outstanding48.47M
Trades Count3.03K
Dollar Volume4.79M
Avg. Volume787.23K
Avg. Weekly Volume997.67K
Avg. Monthly Volume1.85M
Avg. Quarterly Volume971.87K

Provention Bio Inc. (NASDAQ: PRVB) stock closed at 13.56 per share at the end of the most recent trading day (a -5.11% change compared to the prior day closing price) with a volume of 1.35M shares and market capitalization of 673.73M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 13 people. Provention Bio Inc. CEO is Ashleigh Palmer.

The one-year performance of Provention Bio Inc. stock is 24.46%, while year-to-date (YTD) performance is -8.99%. PRVB stock has a five-year performance of %. Its 52-week range is between 4.72 and 18.5, which gives PRVB stock a 52-week price range ratio of 66.62%

Provention Bio Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 11.25, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -69.06%, a ROC of -76.54% and a ROE of -74.74%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Provention Bio Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.27 for the next earnings report. Provention Bio Inc.’s next earnings report date is 04th Aug 2020.

The consensus rating of Wall Street analysts for Provention Bio Inc. is Strong Buy (1.17), with a target price of $28.5, which is +104.89% compared to the current price. The earnings rating for Provention Bio Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Provention Bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Provention Bio Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 15.09, ATR14 : 1.28, CCI20 : -68.89, Chaikin Money Flow : -0.09, MACD : 0.14, Money Flow Index : 38.61, ROC : -15.04, RSI : 45.28, STOCH (14,3) : 7.34, STOCH RSI : 0.00, UO : 37.04, Williams %R : -92.67), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Provention Bio Inc. in the last 12-months were: Anthony Digiandomenico (Buy at a value of $379 950), Ashleigh Palmer (Buy at a value of $145 764), Eleanor L. Ramos (Buy at a value of $28 680), Francisco Leon (Buy at a value of $147 749), Jason Hoitt (Buy at a value of $24 435), Jeffrey Bluestone (Option Excercise at a value of $76 101)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
1 (16.67 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.17
Strong Buy
1.00
Strong Buy
1.00

Provention Bio Inc.

Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.

CEO: Ashleigh Palmer

Teplephone: +1 908 336-0360

Address: P.O. Box 666, Oldwick 08858, NJ, USA

Number of employees: 13

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

46%54%

Bearish Bullish

39%61%

Bearish Bullish

50%50%

News

Stocktwits